Local Institution
Magdeburg 39120
0 studies enrolling now · 12 studies all time
What they study most
Acute Coronary Syndromes, Acute Ischemic Stroke, Advanced Cutaneous Melanoma, Atrial Fibrillation, Bipolar Disorder, Crohn's Disease, Diabetes, Diabetes Mellitus, Type 2, Hepato Cellular Carcinoma (HCC), Transient Ischemic Attack (TIA), Type 2 Diabetes, Unresectable or Metastatic Melanoma
Studies at this site
- A Study on BMS-986177 for the Prevention of a Stroke in Patients Receiving Aspirin and Clopidogrel — Completed
- A Study to Compare BMS-936558 to the Physician's Choice of Either Dacarbazine or Carboplatin and Paclitaxel in Advanced Melanoma Patients That Have Progressed Following Anti-CTLA-4 Therapy (CheckMate 037) — Completed
- A Multi-National, Prospective, Observational Study in Patients With Unresectable or Metastatic Melanoma — Completed
- Dose Ranging Study of BMS-945429 in Subjects With Moderate to Severe Crohn's Disease — Stopped early
- A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart — Completed
- A Phase III Study of Apixaban in Patients With Atrial Fibrillation — Completed
- A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes and Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker — Completed
- A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication — Completed
- First Line Hepato Cellular Carcinoma (HCC) — Completed
- A Phase 3 Study of BMS-477118 in Combination With Metformin in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise — Completed
- Study of Aripiprazole in Patients With Bipolar I Disorder — Completed
- Study Comparing Muraglitazar With Glimepiride in Type 2 Diabetics Who Are Not Controlled With Metformin Alone — Completed